<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39350561</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2052-1707</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Pharmacology research &amp; perspectives</Title><ISOAbbreviation>Pharmacol Res Perspect</ISOAbbreviation></Journal><ArticleTitle>Effect of vitamin D supplementation on clinical outcomes in adult patients with COVID-19: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>e70013</StartPage><MedlinePgn>e70013</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70013</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/prp2.70013</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has emerged as a major global health crisis. Vitamin D, a crucial fat-soluble vitamin, has been recommended for COVID-19 patients, though evidence of its effectiveness is inconsistent. This systematic literature review and meta-analysis aimed to evaluate the impact of vitamin D supplementation on COVID-19-related outcomes. A comprehensive search was conducted across PubMed, Scopus, Web of Science, Embase, and Cochrane databases. Primary outcomes included mortality and hospital length of stay, while secondary outcomes encompassed C-reactive protein (CRP), ferritin, D-dimer, hemoglobin (Hb) concentrations, and lymphocyte, neutrophil, and platelet counts. Data analysis was performed using Stata™ Version 14. A total of 16 trials were analyzed. The meta-analysis revealed that vitamin D supplementation significantly reduced hospital length of stay (mean difference = -1.16; 95% confidence interval [CI]: -2.23, -0.09; p = .033) with significant heterogeneity (I<sup>2</sup> = 69.2%, p = .002). Subgroup analysis showed a more pronounced reduction in studies with vitamin D dosages ≤10 000 international units (IU) (mean difference = -1.27; 95% CI: -1.96, -0.57; p &lt; .001) and in patients over 60 years old (mean difference = -1.84; 95% CI: -2.53, -1.14; p &lt; .001). Additionally, vitamin D significantly reduced CRP concentrations in older adults (&gt;60 years) (mean difference = -1.13; 95% CI: -2.07, -0.18; p = .019). No significant changes were found in ferritin, D-dimer, Hb concentrations, or in lymphocyte, neutrophil, and platelet counts (p &gt; .05). In conclusion, while vitamin D supplementation did not significantly affect most COVID-19-related biomarkers, however, it reduces the length of hospital stay.</AbstractText><CopyrightInformation>© 2024 The Author(s). Pharmacology Research &amp; Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghoreshi</LastName><ForeName>Zohreh-Al-Sadat</ForeName><Initials>ZA</Initials><Identifier Source="ORCID">0000-0002-0556-3000</Identifier><AffiliationInfo><Affiliation>Student Research Committee, Jiroft University of Medical Sciences, Jiroft, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charostad</LastName><ForeName>Javad</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0008-6101-8016</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Science, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arefinia</LastName><ForeName>Nasir</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-7282-3538</Identifier><AffiliationInfo><Affiliation>Student Research Committee, Jiroft University of Medical Sciences, Jiroft, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakhaie</LastName><ForeName>Mohsen</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7605-2593</Identifier><AffiliationInfo><Affiliation>Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rezaei Zadeh Rukerd</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8390-4344</Identifier><AffiliationInfo><Affiliation>Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universal Scientific Education and Research Network (USERN), Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salajegheh</LastName><ForeName>Faranak</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-4368-779X</Identifier><AffiliationInfo><Affiliation>Clinical Research Development Unit, School of Medicine, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pharmacol Res Perspect</MedlineTA><NlmUniqueID>101626369</NlmUniqueID><ISSNLinking>2052-1707</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-73-2</RegistryNumber><NameOfSubstance UI="D005293">Ferritins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014815">Vitamins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000178" MajorTopicYN="N">diet therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005293" MajorTopicYN="N">Ferritins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="Y">Vitamin D</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID‐19</Keyword><Keyword MajorTopicYN="N">meta‐analysis</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">vitamin D</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>2</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39350561</ArticleId><ArticleId IdType="pmc">PMC11442836</ArticleId><ArticleId IdType="doi">10.1002/prp2.70013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sahu KK, Mishra AK, Lal A. COVID‐2019: update on epidemiology, disease spread and management. Monaldi Arch Chest Dis. 2020;90(1):1292.</Citation><ArticleIdList><ArticleId IdType="pubmed">32297723</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafieipour S, Mohammadi E, Rukerd MRZ, et al. Gastrointestinal bleeding: prevalence, etiology, and outcomes in COVID‐19 inpatients. GOVARESH. 2023;28(1):30‐35.</Citation></Reference><Reference><Citation>Nakhaie M, Ghoreshi ZA, Rukerd MRZ, Askarpour H, Arefinia N. Novel mutations in the non‐structure protein 2 of SARS‐CoV‐2. Mediterr J Hematol Infect Dis. 2023;15(1):e2023059. doi:10.4084/MJHID.2023.059</Citation><ArticleIdList><ArticleId IdType="doi">10.4084/MJHID.2023.059</ArticleId><ArticleId IdType="pmc">PMC10631707</ArticleId><ArticleId IdType="pubmed">38028396</ArticleId></ArticleIdList></Reference><Reference><Citation>
Weekly epidemiological update on COVID‐19 – 25 May 2023. Accessed July 14, 2023. https://www.who.int/publications/m/item/weekly‐epidemiological‐update‐on‐covid‐19‐‐‐25‐may‐2023
</Citation></Reference><Reference><Citation>García‐Lledó A, Gómez‐Pavón J, del Castillo JG, et al. Pharmacological treatment of COVID‐19: an opinion paper. Rev Esp Quimioter. 2022;35(2):115‐130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8972693</ArticleId><ArticleId IdType="pubmed">34894208</ArticleId></ArticleIdList></Reference><Reference><Citation>Heustess AM, Allard MA, Thompson DK, Fasinu PS. Clinical management of COVID‐19: a review of pharmacological treatment options. Pharmaceuticals. 2021;14(6):520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8229327</ArticleId><ArticleId IdType="pubmed">34071185</ArticleId></ArticleIdList></Reference><Reference><Citation>Boozari M, Hosseinzadeh H. Natural products for COVID‐19 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytother Res. 2021;35(2):864‐876.</Citation><ArticleIdList><ArticleId IdType="pubmed">32985017</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafieipour S, Rezaei Zadeh Rukerd M, Shamsizadeh Meymandi T, et al. The effect of intravenous tocilizumab therapy on the prognosis of patients with COVID‐19: a case‐control study. Iranian J Med Microbiol. 2023;17(2):243‐250.</Citation></Reference><Reference><Citation>Silverio R, Gonçalves DC, Andrade MF, Seelaender M. Coronavirus disease 2019 (COVID‐19) and nutritional status: the missing link? Adv Nutr. 2021;12(3):682‐692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543263</ArticleId><ArticleId IdType="pubmed">32975565</ArticleId></ArticleIdList></Reference><Reference><Citation>Naja F, Hamadeh R. Nutrition amid the COVID‐19 pandemic: a multi‐level framework for action. Eur J Clin Nutr. 2020;74(8):1117‐1121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167535</ArticleId><ArticleId IdType="pubmed">32313188</ArticleId></ArticleIdList></Reference><Reference><Citation>De Flora S, Balansky R, La Maestra S. Antioxidants and COVID‐19. J Prev Med Hyg. 2021;62(1 Suppl 3):13185‐13193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8452284</ArticleId><ArticleId IdType="pubmed">34622082</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto ME, Guarner‐Lans V, Soria‐Castro E, Manzano Pech L, Pérez‐Torres I. Is antioxidant therapy a useful complementary measure for Covid‐19 treatment? An algorithm for its application. Medicina. 2020;56(8):386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7466376</ArticleId><ArticleId IdType="pubmed">32752010</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisoschi AM, Pop A, Iordache F, et al. Antioxidant, anti‐inflammatory and immunomodulatory roles of vitamins in COVID‐19 therapy. Eur J Med Chem. 2022;232:114175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8813210</ArticleId><ArticleId IdType="pubmed">35151223</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson CR, Thacher TD. Vitamin D: immune function, inflammation, infections and auto‐immunity. Paediatr Int Child Health. 2023;43:1‐11.</Citation><ArticleIdList><ArticleId IdType="pubmed">36857810</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Liu D, Deng F. The role of vitamin D in immune system and inflammatory bowel disease. J Inflamm Res. 2022;15:3167‐3185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9160606</ArticleId><ArticleId IdType="pubmed">35662873</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow CS, Hadi MA, Hasan SS. Reply: vitamin D supplementation in influenza and COVID‐19 infections. Comment on: evidence that vitamin D supplementation could reduce risk of influenza and COVID‐19 infections and deaths. Nutrients 2020, 12 (4), 988. Nutrients. 2020;12(6):1626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7352999</ArticleId><ArticleId IdType="pubmed">32492809</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolliffe DA, Camargo CA, Sluyter JD, et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta‐analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021;9(5):276‐292.</Citation><ArticleIdList><ArticleId IdType="pubmed">33798465</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou YF, Luo BA, Qin LL. The association between vitamin D deficiency and community‐acquired pneumonia: a meta‐analysis of observational studies. Medicine. 2019;98(38):e17252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6756683</ArticleId><ArticleId IdType="pubmed">31567995</ArticleId></ArticleIdList></Reference><Reference><Citation>Siuka D, Saletinger R, Uršič J, et al. The effect of vitamin D levels on the course of COVID‐19 in hospitalized patients–a 1‐year prospective cohort study. F1000Research. 2023;12(254):254.</Citation></Reference><Reference><Citation>Paiz N, Alonso P, Portillo AL. Vitamin D status: can it affect the risk of infection and the severity of COVID‐19 symptoms? Curr Trop Med Rep. 2021;8:1‐8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010782</ArticleId><ArticleId IdType="pubmed">33816060</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Zheng J, Liu Y, Zhou Q, Peng D. Effect of vitamin D status on adult COVID‐19 pneumonia induced by delta variant: a longitudinal, real‐world cohort study. Front Med. 2023;10:1121256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10080157</ArticleId><ArticleId IdType="pubmed">37035323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J, Zhu X, Shi Y, et al. VDR attenuates acute lung injury by blocking Ang‐2‐Tie‐2 pathway and renin‐angiotensin system. Mol Endocrinol. 2013;27(12):2116‐2125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3857197</ArticleId><ArticleId IdType="pubmed">24196349</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaun F, Boesing M, Luethi‐Corridori G, et al. Effect of single high dose vitamin D substitution in hospitalized COVID‐19 patients with vitamin D deficiency on length of hospital stay. Biomedicine. 2023;11(5):1277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10215464</ArticleId><ArticleId IdType="pubmed">37238948</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugarin JD, Dosenovic S, Ilic D, et al. Vitamin D supplementation and clinical outcomes in severe COVID‐19 patients—randomized controlled trial. Nutrients. 2023;15(5):1234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10005311</ArticleId><ArticleId IdType="pubmed">36904232</ArticleId></ArticleIdList></Reference><Reference><Citation>Varikasuvu SR, Thangappazham B, Vykunta A, et al. COVID‐19 and vitamin D (Co‐VIVID study): a systematic review and meta‐analysis of randomized controlled trials. Expert Rev Anti‐Infect Ther. 2022;20(6):907‐913. doi:10.1080/14787210.2022.2035217</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2022.2035217</ArticleId><ArticleId IdType="pmc">PMC8862170</ArticleId><ArticleId IdType="pubmed">35086394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kümmel LS, Krumbein H, Fragkou PC, et al. Vitamin D supplementation for the treatment of COVID‐19: a systematic review and meta‐analysis of randomized controlled trials. Front Immunol. 2022;13:1023903. doi:10.3389/fimmu.2022.1023903</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1023903</ArticleId><ArticleId IdType="pmc">PMC9659578</ArticleId><ArticleId IdType="pubmed">36389703</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi:10.1136/bmj.n160</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n160</ArticleId><ArticleId IdType="pmc">PMC8005925</ArticleId><ArticleId IdType="pubmed">33781993</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi:10.1136/bmj.d5928</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldet G, Howick J. Understanding GRADE: an introduction. J Evid Based Med. 2013;6(1):50‐54. doi:10.1111/jebm.12018</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jebm.12018</ArticleId><ArticleId IdType="pubmed">23557528</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924‐926. doi:10.1136/bmj.39489.470347.AD</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629‐634. doi:10.1136/bmj.315.7109.629</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervero M, López‐Wolf D, Casado G, et al. Beneficial effect of short‐term supplementation of high dose of vitamin D3 in hospitalized patients with COVID‐19: a multicenter, single‐blinded, prospective randomized pilot clinical trial. Front Pharmacol. 2022;13:863587. doi:10.3389/fphar.2022.863587</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.863587</ArticleId><ArticleId IdType="pmc">PMC9289223</ArticleId><ArticleId IdType="pubmed">35860019</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastogi A, Bhansali A, Khare N, et al. Short term, high‐dose vitamin D supplementation for COVID‐19 disease: a randomised, placebo‐controlled, study (SHADE study). Postgrad Med J. 2022;98(1156):87‐90. doi:10.1136/postgradmedj-2020-139065</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-139065</ArticleId><ArticleId IdType="pubmed">33184146</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres M, Casado G, Vigón L, et al. Changes in the immune response against SARS‐CoV‐2 in individuals with severe COVID‐19 treated with high dose of vitamin D. Biomed Pharmacother. 2022;150:112965. doi:10.1016/j.biopha.2022.112965</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.112965</ArticleId><ArticleId IdType="pmc">PMC9008199</ArticleId><ArticleId IdType="pubmed">35468580</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman AR, Abdelaziz TS, Fathy A. Impact of vitamin D therapy on the progress COVID‐19: six weeks follow‐up study of vitamin D deficient elderly diabetes patients. Proc Singap Healthc. 2021;31:20101058211041405. doi:10.1177/20101058211041405</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20101058211041405</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarhan N, Abou Warda AE, Sarhan RM, et al. Evidence for the efficacy of a high dose of vitamin D on the hyperinflammation state in moderate‐to‐severe COVID‐19 patients: a randomized clinical trial. Medicina. 2022;58(10):1358. doi:10.3390/medicina58101358</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58101358</ArticleId><ArticleId IdType="pmc">PMC9609310</ArticleId><ArticleId IdType="pubmed">36295519</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariani J, Antonietti L, Tajer C, et al. High‐dose vitamin D versus placebo to prevent complications in COVID‐19 patients: multicentre randomized controlled clinical trial. PLoS One. 2022;17(5):e0267918. doi:10.1371/journal.pone.0267918</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0267918</ArticleId><ArticleId IdType="pmc">PMC9140264</ArticleId><ArticleId IdType="pubmed">35622854</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamir YM, Amir H, Lim S, et al. A randomized pilot study using calcitriol in hospitalized COVID‐19 patients. Bone. 2022;154:116175. doi:10.1016/j.bone.2021.116175</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2021.116175</ArticleId><ArticleId IdType="pmc">PMC8425676</ArticleId><ArticleId IdType="pubmed">34508882</ArticleId></ArticleIdList></Reference><Reference><Citation>Karonova TL, Golovatyuk KA, Kudryavtsev IV, et al. Effect of cholecalciferol supplementation on the clinical features and inflammatory markers in hospitalized COVID‐19 patients: a randomized, open‐label, single‐center study. Nutrients. 2022;14(13):2602. doi:10.3390/nu14132602</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14132602</ArticleId><ArticleId IdType="pmc">PMC9268385</ArticleId><ArticleId IdType="pubmed">35807783</ArticleId></ArticleIdList></Reference><Reference><Citation>Murai IH, Fernandes AL, Sales LP, et al. Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID‐19: a randomized clinical trial. JAMA. 2021;325(11):1053‐1060. doi:10.1001/jama.2020.26848</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.26848</ArticleId><ArticleId IdType="pmc">PMC7890452</ArticleId><ArticleId IdType="pubmed">33595634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabico S, Enani MA, Sheshah E, et al. Effects of a 2‐week 5000 IU versus 1000 IU vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate Covid‐19: a randomized clinical trial. Nutrients. 2021;13(7):2170. doi:10.3390/nu13072170</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13072170</ArticleId><ArticleId IdType="pmc">PMC8308273</ArticleId><ArticleId IdType="pubmed">34202578</ArticleId></ArticleIdList></Reference><Reference><Citation>Sánchez‐Zuno GA, González‐Estevez G, Matuz‐Flores MG, et al. Vitamin D levels in COVID‐19 outpatients from Western Mexico: clinical correlation and effect of its supplementation. J Clin Med. 2021;10(11):2378. doi:10.3390/jcm10112378</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10112378</ArticleId><ArticleId IdType="pmc">PMC8198869</ArticleId><ArticleId IdType="pubmed">34071293</ArticleId></ArticleIdList></Reference><Reference><Citation>Annweiler C, Beaudenon M, Gautier J, et al. High‐dose versus standard‐dose vitamin D supplementation in older adults with COVID‐19 (COVIT‐TRIAL): a multicenter, open‐label, randomized controlled superiority trial. PLoS Med. 2022;19(5):e1003999. doi:10.1371/journal.pmed.1003999</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003999</ArticleId><ArticleId IdType="pmc">PMC9154122</ArticleId><ArticleId IdType="pubmed">35639792</ArticleId></ArticleIdList></Reference><Reference><Citation>Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, et al. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID‐19: a pilot randomized clinical study. J Steroid Biochem Mol Biol. 2020;203:105751. doi:10.1016/j.jsbmb.2020.105751</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2020.105751</ArticleId><ArticleId IdType="pmc">PMC7456194</ArticleId><ArticleId IdType="pubmed">32871238</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballero‐García A, Pérez‐Valdecantos D, Guallar P, et al. Effect of vitamin D supplementation on muscle status in old patients recovering from COVID‐19 infection. Medicina (Kaunas). 2021;57(10):1079. doi:10.3390/medicina57101079</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57101079</ArticleId><ArticleId IdType="pmc">PMC8537350</ArticleId><ArticleId IdType="pubmed">34684116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilezikian JP, Bikle D, Hewison M, et al. Mechanisms in endocrinology: vitamin D and COVID‐19. Eur J Endocrinol. 2020;183(5):R133‐R147. doi:10.1530/EJE-20-0665</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0665</ArticleId><ArticleId IdType="pmc">PMC9494342</ArticleId><ArticleId IdType="pubmed">32755992</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell F. Vitamin‐D and COVID‐19: do deficient risk a poorer outcome? Lancet Diabetes Endocrinol. 2020;8(7):570. doi:10.1016/S2213-8587(20)30183-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30183-2</ArticleId><ArticleId IdType="pmc">PMC7239633</ArticleId><ArticleId IdType="pubmed">32445630</ArticleId></ArticleIdList></Reference><Reference><Citation>Dancer RCA, Parekh D, Lax S, et al. Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS). Thorax. 2015;70(7):617‐624. doi:10.1136/thoraxjnl-2014-206680</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2014-206680</ArticleId><ArticleId IdType="pmc">PMC4484044</ArticleId><ArticleId IdType="pubmed">25903964</ArticleId></ArticleIdList></Reference><Reference><Citation>Notz Q, Herrmann J, Schlesinger T, et al. Vitamin D deficiency in critically ill COVID‐19 ARDS patients. Clin Nutr. 2022;41(12):3089‐3095. doi:10.1016/j.clnu.2021.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2021.03.001</ArticleId><ArticleId IdType="pmc">PMC7937427</ArticleId><ArticleId IdType="pubmed">33745749</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelidi AM, Belanger MJ, Lorinsky MK, et al. Vitamin D status is associated with in‐hospital mortality and mechanical ventilation: a cohort of COVID‐19 hospitalized patients. Mayo Clin Proc. 2021;96(4):875‐886. doi:10.1016/j.mayocp.2021.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.01.001</ArticleId><ArticleId IdType="pmc">PMC7834253</ArticleId><ArticleId IdType="pubmed">33714594</ArticleId></ArticleIdList></Reference><Reference><Citation>He M, Cao T, Wang J, Wang C, Wang Z, Abdelrahim MEA. Vitamin D deficiency relation to sepsis, paediatric risk of mortality III score, need for ventilation support, length of hospital stay, and duration of mechanical ventilation in critically ill children: a meta‐analysis. Int J Clin Pract. 2021;75(4):e13908. doi:10.1111/ijcp.13908</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13908</ArticleId><ArticleId IdType="pubmed">33280208</ArticleId></ArticleIdList></Reference><Reference><Citation>Gough ME, Graviss EA, May EE. The dynamic immunomodulatory effects of vitamin D3 during Mycobacterium infection. Innate Immun. 2017;23(6):506‐523. doi:10.1177/1753425917719143</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753425917719143</ArticleId><ArticleId IdType="pubmed">28770668</ArticleId></ArticleIdList></Reference><Reference><Citation>Hübel E, Kiefer T, Weber J, Mettang T, Kuhlmann U. In vivo effect of 1,25‐dihydroxyvitamin D3 on phagocyte function in hemodialysis patients. Kidney Int. 1991;40(5):927‐933. doi:10.1038/ki.1991.296</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1991.296</ArticleId><ArticleId IdType="pubmed">1662316</ArticleId></ArticleIdList></Reference><Reference><Citation>White JH. Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: past, present and future. J Steroid Biochem Mol Biol. 2010;121(1–2):234‐238. doi:10.1016/j.jsbmb.2010.03.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2010.03.034</ArticleId><ArticleId IdType="pubmed">20302931</ArticleId></ArticleIdList></Reference><Reference><Citation>Teymoori‐Rad M, Marashi SM. Vitamin D and Covid‐19: from potential therapeutic effects to unanswered questions. Rev Med Virol. 2021;31(2):e2159. doi:10.1002/rmv.2159</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2159</ArticleId><ArticleId IdType="pubmed">32856339</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilani SJ, Bin‐Jumah MN, Nadeem MS, Kazmi I. Vitamin D attenuates COVID‐19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy. Expert Rev Anti‐Infect Ther. 2022;20(2):231‐241. doi:10.1080/14787210.2021.1941871</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2021.1941871</ArticleId><ArticleId IdType="pmc">PMC8477590</ArticleId><ArticleId IdType="pubmed">34112047</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikle DD. Vitamin D regulation of immune function during covid‐19. Rev Endocr Metab Disord. 2022;23(2):279‐285. doi:10.1007/s11154-021-09707-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09707-4</ArticleId><ArticleId IdType="pmc">PMC8799423</ArticleId><ArticleId IdType="pubmed">35091881</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID‐19. Virus Res. 2021;292:198235. doi:10.1016/j.virusres.2020.198235</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198235</ArticleId><ArticleId IdType="pmc">PMC7680047</ArticleId><ArticleId IdType="pubmed">33232783</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng F, Huang Y, Guo Y, et al. Association of inflammatory markers with the severity of COVID‐19: a meta‐analysis. Int J Infect Dis. 2020;96:467‐474. doi:10.1016/j.ijid.2020.05.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.05.055</ArticleId><ArticleId IdType="pmc">PMC7233226</ArticleId><ArticleId IdType="pubmed">32425643</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Shi J, He Z, et al. Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID‐19) patients. Aging (Albany NY). 2020;12(7):6037‐6048. doi:10.18632/aging.102999</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102999</ArticleId><ArticleId IdType="pmc">PMC7185104</ArticleId><ArticleId IdType="pubmed">32275643</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C, Huang Y, Shi F, et al. C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early. J Med Virol. 2020;92(7):856‐862. doi:10.1002/jmv.25871</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25871</ArticleId><ArticleId IdType="pmc">PMC7262341</ArticleId><ArticleId IdType="pubmed">32281668</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas‐Vargas M, Cortés‐Rojo C. Ferritin levels and COVID‐19. Rev Panam Salud Publica. 2020;44:e72. doi:10.26633/RPSP.2020.72</Citation><ArticleIdList><ArticleId IdType="doi">10.26633/RPSP.2020.72</ArticleId><ArticleId IdType="pmc">PMC7286435</ArticleId><ArticleId IdType="pubmed">32547616</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>